"Mamma Mia" for Perinatal Health and Wellness

October 10, 2023 updated by: Virginia Commonwealth University
The purpose of this research study is to find out about ways to enhance well-being during pregnancy and the postpartum period (after the baby is born). The "Mamma Mia" program and/or guided support from study staff ("Mamma Mia Plus") may be helpful because the app provides skills and information related to many important topics during and after pregnancy. This study will allow us to learn more about whether and how the program is helpful to women.

Study Overview

Status

Active, not recruiting

Detailed Description

This study will compare findings in women who do not use the program ("usual care group") versus women who use the program ("Mamma Mia group") versus women who use the program and receive regular contact from study staff ("Mamma Mia Plus"). The study will assess well-being, depression, stress, and anxiety as well as whether certain factors (for example, women's age, type of healthcare provider, amount of social support) are related to the effects of the program. For women randomized to use the program, the study will also collect information about the time spent using it and the modules completed.

Usual prenatal and postpartum care involves regular visits with participant's women's health care provider while pregnant and after the baby is born. In this study, participants will receive continue receiving usual care. In addition, participants will be randomly assigned (like the flip of a coin) to participate in one of the following groups:

  1. The "usual care group", or
  2. The "Mamma Mia group" (which is to use the "Mamma Mia" program regularly), or
  3. The "Mamma Mia Plus group" (which is to use the program regularly plus receive regular contact with study staff).

There is a 1 chance in 3 of being assigned to each of the three groups. participants have an equal chance of being assigned to any one of the groups.

Participants in the "usual care group" will be asked to do the following things:

  1. Complete survey questions at entrance into the study.
  2. Complete survey questions every few months (see schedule below).

Participants in the "Mamma Mia group" will be asked to do the following things:

  1. Complete survey questions at entrance into the study.
  2. Use the "Mamma Mia" program on a regular basis (on average: weekly for about 10 minutes) from entering study until six months postpartum; participants will receive an email reminder to complete modules when they should be completed.
  3. Complete survey questions every few months.

Participants in the "Mamma Mia Plus group" will be asked to do the following things:

  1. Complete survey questions at entrance into the study.
  2. Use the "Mamma Mia" program on a regular basis (on average: weekly for about 10 minutes) from entrance into the study until six months postpartum.
  3. Complete survey questions every few months.
  4. Participants will receive phone calls or emails or texts (depending upon participant preference) from study staff every few months.

Study Type

Interventional

Enrollment (Actual)

1952

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Richmond, Virginia, United States, 23298
        • Virginia Commonwealth University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • pregnant woman <25 weeks gestation;
  • age 18 or older;
  • speak, read, and understand English;
  • have the ability to access an internet/mobile-based program (via computer, tablet, or smartphone), and have a working phone number and a working email address.

Exclusion Criteria:

• none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care group
Usual prenatal and postpartum care involves regular visits with one's health care provider while pregnant and after the baby is born.
Experimental: Mamma Mia group
Usual prenatal/postpartum care plus use of the "Mamma Mia" program

Users of the Mamma Mia program progress through the intervention in a sequence of modules.

Every day that a module should be completed, you will receive a notification with a reminder to access the program. By clicking on the reminder, you can access that particular day's session content. Modules involve a variety of information and activities; for example, there are guided mindfulness practices, information on breastfeeding, instructional videos on how to interpret your baby's cries, and discussions on how to have effective discussions with your partner or healthcare provider about your needs.

Experimental: Mamma Mia Plus group
Usual prenatal/postpartum care plus use of the "Mamma Mia" program plus occasional contacts from study staff

Users of the Mamma Mia program progress through the intervention in a sequence of modules.

Every day that a module should be completed, you will receive a notification with a reminder to access the program. By clicking on the reminder, you can access that particular day's session content. Modules involve a variety of information and activities; for example, there are guided mindfulness practices, information on breastfeeding, instructional videos on how to interpret your baby's cries, and discussions on how to have effective discussions with your partner or healthcare provider about your needs.

Participants will use the Mamma Mia program, plus receive contact (phone calls or emails or texts) from study staff every few months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in depression symptom severity
Time Frame: Baseline to 6 months postpartum, about 11 months
measured by the Edinburgh Postpartum Depression Scale
Baseline to 6 months postpartum, about 11 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in subjective well-being
Time Frame: Baseline to 6 months postpartum, about 11 months
Measured using Satisfaction with Life Scale
Baseline to 6 months postpartum, about 11 months
Change in anxiety
Time Frame: Baseline to 6 months postpartum, about 11 months
Measured by the State-Trait Anxiety Scale
Baseline to 6 months postpartum, about 11 months
Change in stress
Time Frame: Baseline to 6 months postpartum, about 11 months
Measured by the Perceived Stress Scale
Baseline to 6 months postpartum, about 11 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patricia A Kinser, PhD, Virginia Commonwealth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2020

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

March 6, 2020

First Submitted That Met QC Criteria

March 6, 2020

First Posted (Actual)

March 9, 2020

Study Record Updates

Last Update Posted (Actual)

October 12, 2023

Last Update Submitted That Met QC Criteria

October 10, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HM20017197
  • 1R01HD100395 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perinatal Depression

Clinical Trials on Mamma Mia

3
Subscribe